Imunon, Inc. Common Stock (IMNN) is a publicly traded Healthcare sector company. As of September 9, 2026, IMNN trades at $1.56 with a market cap of $8.87M and a P/E ratio of -0.23. IMNN moved +0.00% today. Year to date, IMNN is -59.58%; over the trailing twelve months it is -73.54%. Its 52-week range spans $1.47 to $41.22. Analyst consensus is buy with an average price target of $17.50. Rallies surfaces IMNN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover IMNN: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $17.50.
| Metric | Value |
|---|---|
| Price | $1.56 |
| Market Cap | $8.87M |
| P/E Ratio | -0.23 |
| EPS | $-6.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.22 |
| 52-Week Low | $1.47 |
| Volume | 3.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-14.50M |
| Gross Margin | 0.00% |
2 analysts cover IMNN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.50.